Live Breaking News & Updates on Intiva Biopharma Inc

Stay updated with breaking news from Intiva biopharma inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Nexien BioPharma, Inc. (OTCMKTS:NXEN) Short Interest Update

Nexien BioPharma, Inc. (OTCMKTS:NXEN – Get Free Report) was the recipient of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 28,900 shares, an increase of 28,800.0% from the March 31st total of 100 shares. Based on an average trading volume of 22,100 shares, […] ....

Nexien Biopharma , Intiva Biopharma Inc , Nexien Biopharma Inc , Nexien Biopharma Company Profile , Get Free Report , Nexien Biopharma Daily , Otcmkts Nxen ,

Analyzing Esperion Therapeutics (NASDAQ:ESPR) & Nexien BioPharma (OTCMKTS:NXEN)

Esperion Therapeutics (NASDAQ:ESPR – Free Report) and Nexien BioPharma (OTCMKTS:NXEN – Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk and profitability. Insider and Institutional Ownership 85.5% of Esperion Therapeutics shares […] ....

United States , Ann Arbor , Daiichi Sankyo Europe Gmb , Nexien Biopharma , Intiva Biopharma Inc , Nexien Biopharma Inc , Esperion Therapeutics Inc , Esperion Therapeutics , Free Report , Given Esperion Therapeutic , Daiichi Sankyo Europe Gmbh , Intiva Biopharma , Esperion Therapeutics Daily ,

Nexien BioPharma (OTCMKTS:NXEN) Stock Price Up 20.6%

Nexien BioPharma, Inc. (OTCMKTS:NXEN – Get Rating)’s stock price rose 20.6% on Thursday . The stock traded as high as $0.18 and last traded at $0.18. Approximately 502,523 shares changed hands during trading, an increase of 1,936% from the average daily volume of 24,683 shares. The stock had previously closed at $0.15. The firm’s fifty […] ....

Nexien Biopharma , Nexien Biopharma Inc , Intiva Biopharma Inc , Get Rating , Otcmkts Nxen ,